BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Silantyev AS, Falzone L, Libra M, Gurina OI, Kardashova KS, Nikolouzakis TK, Nosyrev AE, Sutton CW, Mitsias PD, Tsatsakis A. Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics. Cells 2019;8:E863. [PMID: 31405017 DOI: 10.3390/cells8080863] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 20.7] [Reference Citation Analysis]
Number Citing Articles
1 Kalita O, Sporikova Z, Hajduch M, Megova Houdova M, Slavkovsky R, Hrabalek L, Halaj M, Klementova Y, Dolezel M, Drabek J, Tuckova L, Ehrmann J Jr, Vrbkova J, Trojanec R, Vaverka M. The Influence of Gene Aberrations on Survival in Resected IDH Wildtype Glioblastoma Patients: A Single-Institution Study. Curr Oncol 2021;28:1280-93. [PMID: 33801093 DOI: 10.3390/curroncol28020122] [Reference Citation Analysis]
2 Paranthaman S, Goravinahalli Shivananjegowda M, Mahadev M, Moin A, Hagalavadi Nanjappa S, Nanjaiyah N, Chidambaram SB, Gowda DV. Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management. Pharmaceutics 2020;12:E1198. [PMID: 33321953 DOI: 10.3390/pharmaceutics12121198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Le Fèvre C, Constans JM, Chambrelant I, Antoni D, Bund C, Leroy-Freschini B, Schott R, Cebula H, Noël G. Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 - Radiological features and metric markers. Crit Rev Oncol Hematol 2021;159:103230. [PMID: 33515701 DOI: 10.1016/j.critrevonc.2021.103230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
4 Yu M, Yu S, Zhou W, Yi B, Liu Y. HOXC6/8/10/13 predict poor prognosis and associate with immune infiltrations in glioblastoma. Int Immunopharmacol 2021;101:108293. [PMID: 34763232 DOI: 10.1016/j.intimp.2021.108293] [Reference Citation Analysis]
5 Giambò F, Leone GM, Gattuso G, Rizzo R, Cosentino A, Cinà D, Teodoro M, Costa C, Tsatsakis A, Fenga C, Falzone L. Genetic and Epigenetic Alterations Induced by Pesticide Exposure: Integrated Analysis of Gene Expression, microRNA Expression, and DNA Methylation Datasets. Int J Environ Res Public Health 2021;18:8697. [PMID: 34444445 DOI: 10.3390/ijerph18168697] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bufalieri F, Caimano M, Lospinoso Severini L, Basili I, Paglia F, Sampirisi L, Loricchio E, Petroni M, Canettieri G, Santoro A, D'Angelo L, Infante P, Di Marcotullio L. The RNA-Binding Ubiquitin Ligase MEX3A Affects Glioblastoma Tumorigenesis by Inducing Ubiquitylation and Degradation of RIG-I. Cancers (Basel) 2020;12:E321. [PMID: 32019099 DOI: 10.3390/cancers12020321] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
7 Wallace DR, Taalab YM, Heinze S, Tariba Lovaković B, Pizent A, Renieri E, Tsatsakis A, Farooqi AA, Javorac D, Andjelkovic M, Bulat Z, Antonijević B, Buha Djordjevic A. Toxic-Metal-Induced Alteration in miRNA Expression Profile as a Proposed Mechanism for Disease Development. Cells 2020;9:E901. [PMID: 32272672 DOI: 10.3390/cells9040901] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
8 Rogachev AD, Alemasov NA, Ivanisenko VA, Ivanisenko NV, Gaisler EV, Oleshko OS, Cheresiz SV, Mishinov SV, Stupak VV, Pokrovsky AG. Correlation of Metabolic Profiles of Plasma and Cerebrospinal Fluid of High-Grade Glioma Patients. Metabolites 2021;11:133. [PMID: 33669010 DOI: 10.3390/metabo11030133] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Zhang L, Zhang P, Tan Y, Feng Q, Zhao R. MicroRNA-522-3p plays an oncogenic role in glioblastoma through activating Wnt/β-catenin signaling pathway via targeting SFRP2. Neuroreport 2021;32:88-98. [PMID: 33395185 DOI: 10.1097/WNR.0000000000001565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Shaw P, Kumar N, Privat-Maldonado A, Smits E, Bogaerts A. Cold Atmospheric Plasma Increases Temozolomide Sensitivity of Three-Dimensional Glioblastoma Spheroids via Oxidative Stress-Mediated DNA Damage. Cancers (Basel) 2021;13:1780. [PMID: 33917880 DOI: 10.3390/cancers13081780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Stanzani E, Pedrosa L, Bourmeau G, Anezo O, Noguera-Castells A, Esteve-Codina A, Passoni L, Matteoli M, de la Iglesia N, Seano G, Martínez-Soler F, Tortosa A. Dual Role of Integrin Alpha-6 in Glioblastoma: Supporting Stemness in Proneural Stem-Like Cells While Inducing Radioresistance in Mesenchymal Stem-Like Cells. Cancers (Basel) 2021;13:3055. [PMID: 34205341 DOI: 10.3390/cancers13123055] [Reference Citation Analysis]
12 Tuaeva NO, Falzone L, Porozov YB, Nosyrev AE, Trukhan VM, Kovatsi L, Spandidos DA, Drakoulis N, Kalogeraki A, Mamoulakis C, Tzanakakis G, Libra M, Tsatsakis A. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements. Cells 2019;8:E1251. [PMID: 31615102 DOI: 10.3390/cells8101251] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
13 Delinois LJ, Peón H, Villalobos-Santos JC, Ramírez-Paz J, Miller J, Griebenow KH, Tinoco AD. A Cytochrome c-Chlorotoxin Hybrid Protein as a Possible Antiglioma Drug. ChemMedChem 2020;15:2185-92. [PMID: 32918396 DOI: 10.1002/cmdc.202000373] [Reference Citation Analysis]
14 Simionescu N, Zonda R, Petrovici AR, Georgescu A. The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy. Pharmaceutics 2021;13:988. [PMID: 34210109 DOI: 10.3390/pharmaceutics13070988] [Reference Citation Analysis]
15 Renner O, Burkard M, Michels H, Vollbracht C, Sinnberg T, Venturelli S. Parenteral high‑dose ascorbate - A possible approach for the treatment of glioblastoma (Review). Int J Oncol 2021;58:35. [PMID: 33955499 DOI: 10.3892/ijo.2021.5215] [Reference Citation Analysis]
16 Cherkasova O, Peng Y, Konnikova M, Kistenev Y, Shi C, Vrazhnov D, Shevelev O, Zavjalov E, Kuznetsov S, Shkurinov A. Diagnosis of Glioma Molecular Markers by Terahertz Technologies. Photonics 2021;8:22. [DOI: 10.3390/photonics8010022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kirstein A, Schmid TE, Combs SE. The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme. Cancers (Basel) 2020;12:E1099. [PMID: 32354046 DOI: 10.3390/cancers12051099] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
18 Napoli S, Scuderi C, Gattuso G, Bella VD, Candido S, Basile MS, Libra M, Falzone L. Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma. Cells 2020;9:E1151. [PMID: 32392801 DOI: 10.3390/cells9051151] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
19 de Oliveira DCS, de Freitas CF, Calori IR, Goncalves RS, Cardinali CAEF, Malacarne LC, Ravanelli MI, de Oliveira HPM, Tedesco AC, Caetano W, Hioka N, Tessaro AL. Theranostic verteporfin- loaded lipid-polymer liposome for photodynamic applications. J Photochem Photobiol B 2020;212:112039. [PMID: 33002779 DOI: 10.1016/j.jphotobiol.2020.112039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Doukas SG, Vageli DP, Lazopoulos G, Spandidos DA, Sasaki CT, Tsatsakis A. The Effect of NNK, A Tobacco Smoke Carcinogen, on the miRNA and Mismatch DNA Repair Expression Profiles in Lung and Head and Neck Squamous Cancer Cells. Cells 2020;9:E1031. [PMID: 32326378 DOI: 10.3390/cells9041031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Yeini E, Ofek P, Albeck N, Rodriguez Ajamil D, Neufeld L, Eldar‐boock A, Kleiner R, Vaskovich D, Koshrovski‐michael S, Dangoor SI, Krivitsky A, Burgos Luna C, Shenbach‐koltin G, Goldenfeld M, Hadad O, Tiram G, Satchi‐fainaro R. Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches. Adv Therap 2021;4:2000124. [DOI: 10.1002/adtp.202000124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
22 Zeng C, Wang J, Li M, Wang H, Lou F, Cao S, Lu C. Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis. Cancer Manag Res 2021;13:3573-88. [PMID: 33953611 DOI: 10.2147/CMAR.S291681] [Reference Citation Analysis]
23 d'Angelo M, Castelli V, Benedetti E, Antonosante A, Catanesi M, Dominguez-Benot R, Pitari G, Ippoliti R, Cimini A. Theranostic Nanomedicine for Malignant Gliomas. Front Bioeng Biotechnol 2019;7:325. [PMID: 31799246 DOI: 10.3389/fbioe.2019.00325] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
24 Guler EM, Sisman BH, Kocyigit A, Hatiboglu MA. Investigation of cellular effects of thymoquinone on glioma cell. Toxicol Rep 2021;8:162-70. [PMID: 33489775 DOI: 10.1016/j.toxrep.2020.12.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Takashima Y, Kawaguchi A, Yamanaka R. Promising Prognosis Marker Candidates on the Status of Epithelial-Mesenchymal Transition and Glioma Stem Cells in Glioblastoma. Cells 2019;8:E1312. [PMID: 31653034 DOI: 10.3390/cells8111312] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
26 Zreik J, Moinuddin FM, Yolcu YU, Alvi MA, Chaichana KL, Quinones-hinojosa A, Bydon M. Improved 3-year survival rates for glioblastoma multiforme are associated with trends in treatment: analysis of the national cancer database from 2004 to 2013. J Neurooncol 2020;148:69-79. [DOI: 10.1007/s11060-020-03469-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
27 Rahmati Y, Alivand M, Mollanoori H. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study. Comput Biol Chem 2021;92:107458. [PMID: 33761401 DOI: 10.1016/j.compbiolchem.2021.107458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ni H, Zhi R, Zuo J, Liu W, Xie P, Zhi Z. Pseudogene ANXA2P2 knockdown shows tumor-suppressive function by inhibition of the PI3K/PKB pathway in glioblastoma cells. J Biochem Mol Toxicol 2021;35:e22824. [PMID: 34047431 DOI: 10.1002/jbt.22824] [Reference Citation Analysis]
29 Zhang Z, Chen J, Huo X, Zong G, Huang K, Cheng M, Sun L, Yue X, Bian E, Zhao B. Identification of a mesenchymal-related signature associated with clinical prognosis in glioma. Aging (Albany NY) 2021;13:12431-55. [PMID: 33875619 DOI: 10.18632/aging.202886] [Reference Citation Analysis]
30 Potapov AA, Chobulov SA, Nikitin PV, Okhlopkov VA, Goryaynov SA, Kosyr'kova AV, Maryakhin AD, Chelushkin DM, Ryzhova MV, Zakharova NE, Batalov AI, Pronin IN, Danilov GV, Savel'eva TA, Loshchenov VB, Yashin KS, Chekhonin VP. [Intraoperative vascular fluorescence in cerebral glioblastomas and vascular histological features]. Zh Vopr Neirokhir Im N N Burdenko 2019;83:21-34. [PMID: 32031165 DOI: 10.17116/neiro20198306121] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Phipps MD, Sanders VA, Deri MA. Current State of Targeted Radiometal-Based Constructs for the Detection and Treatment of Disease in the Brain. Bioconjug Chem 2021;32:1331-47. [PMID: 34015928 DOI: 10.1021/acs.bioconjchem.1c00180] [Reference Citation Analysis]
32 Mencke P, Hanss Z, Boussaad I, Sugier PE, Elbaz A, Krüger R. Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme. Front Neurol 2020;11:898. [PMID: 32973662 DOI: 10.3389/fneur.2020.00898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
33 Ke XX, Zhang R, Zhong X, Zhang L, Cui H. Deficiency of G9a Inhibits Cell Proliferation and Activates Autophagy via Transcriptionally Regulating c-Myc Expression in Glioblastoma. Front Cell Dev Biol 2020;8:593964. [PMID: 33330479 DOI: 10.3389/fcell.2020.593964] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
34 Liu F, Xing D, Zha Y, Wang L, Dong W, Li L, Gong W, Hu L. Predictive Value of Temporal Muscle Thickness Measurements on Cranial Magnetic Resonance Images in the Prognosis of Patients With Primary Glioblastoma. Front Neurol 2020;11:523292. [PMID: 33304303 DOI: 10.3389/fneur.2020.523292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wu X, Wang X, Wang J, Hao Y, Liu F, Wang X, Yang L, Lu Z. The Roles of Exosomes as Future Therapeutic Agents and Diagnostic Tools for Glioma. Front Oncol 2021;11:733529. [PMID: 34722277 DOI: 10.3389/fonc.2021.733529] [Reference Citation Analysis]
36 Bannaga A, Metzger J, Voigtländer T, Pejchinovski M, Frantzi M, Book T, James S, Gopalakrishnan K, Mischak H, Manns MP, Arasaradnam RP. Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:3786. [PMID: 34359689 DOI: 10.3390/cancers13153786] [Reference Citation Analysis]
37 Yang L, Zeng W, Sun H, Huang F, Yang C, Cai X, Lu Y, Zeng J, Yang K. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis. World Neurosurg 2020;138:e492-514. [PMID: 32147549 DOI: 10.1016/j.wneu.2020.02.159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
38 Aloizou AM, Pateraki G, Siokas V, Mentis AA, Liampas I, Lazopoulos G, Kovatsi L, Mitsias PD, Bogdanos DP, Paterakis K, Dardiotis E. The role of MiRNA-21 in gliomas: Hope for a novel therapeutic intervention? Toxicol Rep 2020;7:1514-30. [PMID: 33251119 DOI: 10.1016/j.toxrep.2020.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
39 Tribe AKW, McConnell MJ, Teesdale-Spittle PH. The Big Picture of Glioblastoma Malignancy: A Meta-Analysis of Glioblastoma Proteomics to Identify Altered Biological Pathways. ACS Omega 2021;6:24535-44. [PMID: 34604635 DOI: 10.1021/acsomega.1c02991] [Reference Citation Analysis]
40 Jiang L, Zhong M, Chen T, Zhu X, Yang H, Lv K. Gene regulation network analysis reveals core genes associated with survival in glioblastoma multiforme. J Cell Mol Med 2020;24:10075-87. [PMID: 32696617 DOI: 10.1111/jcmm.15615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Ren B, Wang L, Nan Y, Liu T, Zhao L, Ma H, Li J, Zhang Y, Ren X. RAB1A regulates glioma cellular proliferation and invasion via the mTOR signaling pathway and epithelial-mesenchymal transition. Future Oncol 2021;17:3203-16. [PMID: 33947216 DOI: 10.2217/fon-2021-0116] [Reference Citation Analysis]
42 Yang Y, Chu L, Zeng Z, Xu S, Yang H, Zhang X, Jia J, Long N, Hu Y, Liu J. Four specific biomarkers associated with the progression of glioblastoma multiforme in older adults identified using weighted gene co-expression network analysis. Bioengineered 2021;12:6643-54. [PMID: 34516348 DOI: 10.1080/21655979.2021.1975980] [Reference Citation Analysis]
43 Fan Z, Xu Q, Wang C, Lin X, Zhang Q, Wu N. A tropomyosin-like Meretrix meretrix Linnaeus polypeptide inhibits the proliferation and metastasis of glioma cells via microtubule polymerization and FAK/Akt/MMPs signaling. Int J Biol Macromol 2020;145:154-64. [PMID: 31866539 DOI: 10.1016/j.ijbiomac.2019.12.158] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Arias-Ramos N, Ibarra LE, Serrano-Torres M, Yagüe B, Caverzán MD, Chesta CA, Palacios RE, López-Larrubia P. Iron Oxide Incorporated Conjugated Polymer Nanoparticles for Simultaneous Use in Magnetic Resonance and Fluorescent Imaging of Brain Tumors. Pharmaceutics 2021;13:1258. [PMID: 34452219 DOI: 10.3390/pharmaceutics13081258] [Reference Citation Analysis]
45 Nikolouzakis TK, Falzone L, Lasithiotakis K, Krüger-Krasagakis S, Kalogeraki A, Sifaki M, Spandidos DA, Chrysos E, Tsatsakis A, Tsiaoussis J. Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin Cancer. J Clin Med 2020;9:E2868. [PMID: 32899768 DOI: 10.3390/jcm9092868] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
46 Wu ATH, Huang HS, Wen YT, Lawal B, Mokgautsi N, Huynh TT, Hsiao M, Wei L. A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling. Cells 2021;10:2391. [PMID: 34572040 DOI: 10.3390/cells10092391] [Reference Citation Analysis]
47 Petre G, Durand H, Pelletier L, Poulenard M, Nugue G, Ray PF, Rendu J, Coutton C, Berger F, Bidart M. Rapid Proteomic Profiling by MALDI-TOF Mass Spectrometry for Better Brain Tumor Classification. Proteomics Clin Appl 2020;14:e1900116. [PMID: 32198817 DOI: 10.1002/prca.201900116] [Reference Citation Analysis]
48 Riess C, Koczan D, Schneider B, Linke C, Del Moral K, Classen CF, Maletzki C. Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models. Cell Death Discov 2021;7:54. [PMID: 33723248 DOI: 10.1038/s41420-021-00423-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 Liu X, Chen F, Li W. Elevated expression of DOK3 indicates high suppressive immune cell infiltration and unfavorable prognosis of gliomas. Int Immunopharmacol 2020;83:106400. [PMID: 32193105 DOI: 10.1016/j.intimp.2020.106400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
50 Krasanakis T, Nikolouzakis TK, Sgantzos M, Mariolis-Sapsakos T, Souglakos J, Spandidos DA, Tsitsimpikou C, Tsatsakis A, Tsiaoussis J. Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review). Oncol Rep 2019;42:2228-44. [PMID: 31578582 DOI: 10.3892/or.2019.7351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
51 Wang Z, Gao L, Guo X, Wang Y, Wang Y, Ma W, Guo Y, Xing B. A novel hypoxic tumor microenvironment signature for predicting the survival, progression, immune responsiveness and chemoresistance of glioblastoma: a multi-omic study. Aging (Albany NY) 2020;12:17038-61. [PMID: 32857727 DOI: 10.18632/aging.103626] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
52 Chen L, Qin D, Guo X, Wang Q, Li J. Putting Proteomics Into Immunotherapy for Glioblastoma. Front Immunol 2021;12:593255. [PMID: 33708196 DOI: 10.3389/fimmu.2021.593255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Duggan MR, Weaver M, Khalili K. PAM (PIK3/AKT/mTOR) signaling in glia: potential contributions to brain tumors in aging. Aging (Albany NY) 2021;13:1510-27. [PMID: 33472174 DOI: 10.18632/aging.202459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Rahman MH, Rana HK, Peng S, Hu X, Chen C, Quinn JMW, Moni MA. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression. Brief Bioinform 2021:bbaa365. [PMID: 33406529 DOI: 10.1093/bib/bbaa365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Wan Y, Zhou S, Zhang Y, Deng X, Xu L. Radiomic Analysis of Contrast-Enhanced MRI Predicts DNA Copy-Number Subtype and Outcome in Lower-Grade Gliomas. Acad Radiol 2021:S1076-6332(21)00488-8. [PMID: 34916150 DOI: 10.1016/j.acra.2021.10.014] [Reference Citation Analysis]
56 Jean-Quartier C, Jeanquartier F, Holzinger A. Open Data for Differential Network Analysis in Glioma. Int J Mol Sci 2020;21:E547. [PMID: 31952211 DOI: 10.3390/ijms21020547] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
57 Li D, Bonner ER, Wierzbicki K, Panditharatna E, Huang T, Lulla R, Mueller S, Koschmann C, Nazarian J, Saratsis AM. Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR. Sci Rep 2021;11:5098. [PMID: 33658570 DOI: 10.1038/s41598-021-84513-1] [Reference Citation Analysis]
58 Mukherjee S, Pillai PP. Current insights on extracellular vesicle-mediated glioblastoma progression: Implications in drug resistance and epithelial-mesenchymal transition. Biochim Biophys Acta Gen Subj 2021;1866:130065. [PMID: 34902452 DOI: 10.1016/j.bbagen.2021.130065] [Reference Citation Analysis]
59 Guidotti G, Brambilla L, Rossi D. Exploring Novel Molecular Targets for the Treatment of High-Grade Astrocytomas Using Peptide Therapeutics: An Overview. Cells 2020;9:E490. [PMID: 32093304 DOI: 10.3390/cells9020490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
60 La Rosa GRM, Gattuso G, Pedullà E, Rapisarda E, Nicolosi D, Salmeri M. Association of oral dysbiosis with oral cancer development. Oncol Lett 2020;19:3045-58. [PMID: 32211076 DOI: 10.3892/ol.2020.11441] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
61 Wagner PM, Prucca CG, Caputto BL, Guido ME. Adjusting the Molecular Clock: The Importance of Circadian Rhythms in the Development of Glioblastomas and Its Intervention as a Therapeutic Strategy. Int J Mol Sci 2021;22:8289. [PMID: 34361055 DOI: 10.3390/ijms22158289] [Reference Citation Analysis]
62 Klamminger GG, Gérardy JJ, Jelke F, Mirizzi G, Slimani R, Klein K, Husch A, Hertel F, Mittelbronn M, Kleine-Borgmann FB. Application of Raman spectroscopy for detection of histologically distinct areas in formalin-fixed paraffin-embedded glioblastoma. Neurooncol Adv 2021;3:vdab077. [PMID: 34355170 DOI: 10.1093/noajnl/vdab077] [Reference Citation Analysis]